Haemonetics CorporationHAENYSE
Loading
EBITDA Over TimeStrong
Percentile Rank100
3Y CAGR+14.2%
5Y CAGR+15.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+14.2%/yr
vs +6.9%/yr prior
5Y CAGR
+15.3%/yr
Consistent
Acceleration
+7.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$375.47M+5.5%
2025$355.99M+20.5%
2024$295.45M+17.2%
2023$252.01M+31.4%
2022$191.72M+4.0%
2021$184.38M-28.5%
2020$257.93M+33.7%
2019$192.96M+26.1%
2018$153.03M+24.2%
2017$123.25M-